A study demonstrated that stimulation of this dural lymphatic drainage using VEGF-C in glioma models increased the efficacy of immune checkpoint inhibitors such as anti-PD1 and CTLA-4 [6]. The gene discussed is VEGFC; the disease is central nervous system cancer.